A chromosomal inversion leading to the fusion of the anaplastic lymphoma kinase (ALK) gene with the echinoderm microtubule-associated protein-like 4 (EML4) gene was identified in 2007 [1], resulting in the EML4-ALK fusion protein, a therapeutic target in advanced non-small-cell lung cancer (NSCLC). Here, EML4 is linked to non-small cell lung carcinoma.